Increasing the use of AI in suckler herds. by Diskin, Michael G. et al.
INCREASING THE USE OF AI IN
SUCKLER HERDS
Authors
M.G. Diskin, M. O’Rourke, J.F. Roche (UCD) & J.M. Sreenan
The work summarised in this report was carried out at Belclare and Athenry
Research Centres as part of the Teagasc Beef Research Programme.
Teagasc acknowledges support from the Operational Programme for Agriculture,
Rural Development and Forestry, 1994-1999. 
Measure 5 (b), Research Stimulus Fund
Project No. 4361
Beef Production Series No. 33
Teagasc,
19 Sandymount Avenue,
Ballsbridge,
Dublin 4.
May 2001
ISBN No. 1 84170 192 0
1
2CONTENTS
Summary 3
General Introduction 7
Study 1 7
Background 7
Material and Methods 8
Results 9
Discussion 14
Study 2 16
Background 16
Material and Methods 16
Results 18
Discussion 26
Study 3 27
Background 27
Material and Methods 28
Results 29
Discussion 34
Conclusions 36
Publications 39
Acknowledgements
The authors acknowledge the skilled technical assistance of P. Joyce, W.
Connolly, J. Nally, G. Morris, Ms A. Glynn, Ms N. Hynes (UCD) and P. Reilly,
P. Creaven, G. Burke and G. McHugh for care of animals. The authors also
acknowledge South Western Cattle Breeding Station, Bandon Co. Cork and
North Eastern Cattle Breeding Station, Ballyhaise, Co. Cavan for assistance with
the farm-trial studies. M. O’Rourke was a recipient of a Teagasc Walsh Fellow.
SUMMARY
Reproductive efficiency is a major factor affecting production and
economic efficiency of beef herds. For herds using artificial insemination
(AI) heat detection rate and calving rate are the two major determinants
of compactness of calving and ultimately to the calving-to-calving
interval. Heat detection rate is hugely variable from herd-to-herd but for
most herds only 40 to 70% of cows that exhibit heat are actually detected
in heat by the stockman. The objective of the this project was to develop
an improved cost effective hormonal method to control the time of
ovulation to allow beef cows be bred by AI without the need for heat
detection. A total of 3 studies were carried out. The main results are
summarised in this publication.
The administration of exogenous oestradiol by injection, in the form of
oestradiol benzoate (ODB), resulted in dose-dependent increase in peak
plasma oestradiol and a dose-dependent transient decrease in follicle
stimulating hormone (FSH) in ovariectomised heifers.  Administration
of higher doses (5mg and 10mg) of oestradiol by capsule attached to a
progesterone releasing intravaginal devise generated much lower plasma
concentrations of oestradiol compared with the lowest dose (0.75mg) of
ODB administered intramuscularly. Both the maximum % decline in
FSH and interval to FSH nadir were related to peak concentrations of
oestradiol. Plasma concentrations of FSH began to increase 1-2 days
after ODB administration while concentrations of oestradiol were
declining but still high.
The results of Experiment 2 clearly showed that the administration of
ODB, causes a dose-dependent increased in plasma concentrations of
oestradiol and a dose-dependent decrease in plasma FSH in intact
heifers, and, in a high proportion of animals causes atresia of the follicle
wave present at treatment initiation followed by the emergence of new
follicle wave 3 to 6 days later. This study also clearly demonstrated that
the administration of oestradiol, by a capsule attached to the
progesterone releasing device, was the least effective way of administering
oestradiol in terms of its ability to generate plasma concentrations of 5-
3
15 pg/ml which, would appear to be required to terminate the current
follicle wave and cause new wave emergence. Plasma concentrations of 3-
5 pg/ml generated by the gelatine capsule attached to the progesterone
releasing device were insufficient to consistently ensure new emergence
but were sufficient to shorten the lifespan of the corpus luteum (CL).
This is the first study to demonstrate that a lower dose of oestradiol is
required to shorten the lifespan of the CL than is required to alter follicle
wave dynamics. 
The results of this study highlight the difficulty of obtaining a tight
synchrony of heat in animals that are at the early stages of their oestrous
cycles at time of treatment initiation. The use of oestradiol at the
beginning of a progesterone synchronisation treatment, even when the
duration of the treatment is extended to 12 days, does not ensure that
corpus luteum regression is complete in all animals at the time of
progesterone withdrawal, thus allowing animals to exhibit a synchronous
heat. Consequently, there is a requirement to administer a luteolytic
agent like prostaglandin F2α or one of its analogues at or before
progesterone withdrawal to ensure complete corpus luteum regression.
While there was clear evidence that administration of oestradiol by
injection was superior to administration by a capsule, attached the
progesterone releasing device, there was no evidence of any beneficial
effects of increasing the dose of oestradiol from 0.75 mg/animal to
5 mg/animal in terms of controlling follicle wave dynamics, shortening
the lifespan of the corpus luteum, or in terms of synchrony of heat or
overall heat response. 
In the farm trial studies (Experiment 3) there was no effect of
progesterone duration (8-day versus 12-day) on oestrous response in
either beef cows or heifers though in the latter oestrous response tended
to be higher following an 8-day treatment. Similarly, duration of
treatment had no effect on the synchrony of the oestrous response
following withdrawal of the progesterone though there was some
evidence of a more highly synchronised oestrous response following the
8-day treatment. 
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5The use of 1.0-mg oestradiol 24 hours after progesterone removal
significantly increased synchronised oestrous response in beef cows.
However, in beef heifers oestrous response at 91% in the non-ODB
treated heifers was already high and would have been difficult to improve
upon. 
The use of ODB improved the synchrony of the oestrous response with
almost all cows exhibiting oestrus on Day 2 following withdrawal of the
progesterone. This highly synchronised oestrous would allow one fixed-
timed AI at about 54-56 hours after withdrawal of the progesterone. In
cows there was a tendency for the pregnancy rate to be higher following
an 8-day than a 12-day duration progesterone treatment. The
administration of ODB had no effect on pregnancy rate in beef cows but
significantly reduced pregnancy rate in heifers. It would appear that the
dosage used in heifers was excessive and that a lower dose might be more
appropriate. However, the high and synchronous oestrous response
recorded in heifers would obviate the need to use ODB 24 hours after
progesterone removal in heifers. 
In cows the overall benefit of using ODB is evident by the higher
conception rate (+7 percentage points) at the synchronised oestrus. This
results from a small increase in both the oestrous response and pregnancy
rate in ODB-treated cows.
6The insemination of animals, preferably once at a specific time without
recourse to oestrous detection and with repeatable high pregnancy rates,
would allow for greater use of proven AI sires on beef cows thereby
increasing the quality of cattle from the beef cow herd.
GENERAL INTRODUCTION
Reproductive efficiency is a major factor affecting production and
economic efficiency of beef herds. For herds using artificial insemination
(AI) heat detection rate and calving rate are the two major determinants
of compactness of calving and ultimately the calving-to-calving interval.
Heat detection is a time consuming repetitive chore that must be carried
out up to 5-times each day for as long as AI is used.  Heat detection rate,
usually measured as submission rate, is hugely variable from herd-to-
herd but for most herds only between 40% and 70% of cows that exhibit
heat are actually detected by the stockman. Despite an increased
understanding of the endocrine control of the oestrous cycle the goal of
fixed-time insemination is not yet consistently achievable in either cows
or heifers treated at different stages of the oestrous cycle and in different
physiological states. The overall objective of the this project was to
develop an improved cost effective hormonal method to control the time
of ovulation to allow beef cows be bred by AI without the need for heat
detection. A total of 3 studies were carried out and the results are
summarised in this report. 
Study 1. 
The effect of dose and route of oestradiol benzoate
administration on plasma concentrations of oestradiol and
follicle stimulating hormone in long-term ovariectomised
heifers
Background
Follicle growth in cattle is a highly regulated process under the control
of FSH, LH and local intra-follicular growth factors.  There are recurrent
waves of follicular growth throughout the oestrous cycle and most of
pregnancy, and they resume early in the postpartum period.  Each wave
begins with the emergence of a cohort of oestrogen active follicles of 3-
5 mm in diameter, preceded by an increase in concentrations of FSH.
This is followed by the selection generally of one dominant follicle (DF)
which occurs in association with declining FSH concentrations.  Finally
the fate of the DF is determined by LH pulse frequency, where
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infrequent pulses (1 every 3-4 hours) lead to DF atresia while more
frequent pulses  (1 per hour)  lead  to ovulation.  Thus, each wave has an 
inherent life span, determined by the interval from wave emergence to
dominance and the duration of dominance.  The duration of dominance
is dependent on the number of waves (2 or 3) during the oestrous cycle,
and on the influence of nutrition, lactation and suckling during the
postpartum period. 
The factors that regulate the recurrent FSH increases are mainly of
ovarian origin, particularly from the DF, with oestradiol (E2) one of the
key intra-follicular components involved.  The relationship between
systemic E2 and FSH concentrations however, is unclear and the
reported effects of E2 on FSH are inconsistent.  The ability to
exogenously regulate FSH concentrations in cattle is important to
synchronise follicle wave development in both, cyclic and anoestrous
cattle. It is necessary to control follicle wave dynamics as well as luteal
function in order to have a ‘healthy’ DF present at the end of treatment.
Both oestradiol and progesterone used together can synchronise follicle
waves, but with variable success.  However, the optimum dose of
oestradiol necessary to suppress FSH is not clear, neither is the effect of
route of administration of oestradiol on plasma concentrations of
oestradiol known.  The specific objective of this experiment was to
determine the effect of dose and route of oestradiol administration at
time of progesterone administration on plasma concentrations of FSH
and oestradiol in order to select the optimum dose to manipulate follicle
waves in subsequent studies.  In this experiment, ovariectomised animals
were used to prevent possible confounding effects of endogenous
oestradiol on plasma concentrations generated by the different routes
and doses used. 
Materials and methods
Thirty-four long-term ovariectomised crossbred beef heifers; 18-24
months of age and weighing 350-480 kg were used.  All heifers received
a progesterone releasing intravaginal device for 7 days in order to
simulate luteal phase concentrations of progesterone before treatment.
Four days after removal of the first progesterone-releasing device, a new
device was inserted for a further 7 days. Animals were randomly
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allocated to receive one of eight oestradiol benzoate (ODB) treatments
at this time; 1) 0.0 mg (Control; n = 3), 2) 0.5 mg (n = 4), 3) 1 mg (n
= 4), 4) 2.5 mg (n = 6), 5) 5 mg (n = 4), 6) 10 mg (n = 4) all
administered by intramuscular injection in 2 ml of corn oil and 7) 5 mg
(n = 4) and 8) 10 mg (n = 5) ODB in powder form administered by
gelatine capsule attached to the progesterone releasing device.  
Blood sampling and hormone assay
Frequent blood samples were collected by jugular venipuncture for
subsequent oestradiol and FSH determinations. Plasma concentrations
of FSH and oestradiol were determined by radioimmunoassays. 
Statistical analyses
The E2 and FSH data were subjected to repeated measures analyses of
variance followed by regression analyses. Because of the between animal
variability, concentrations of FSH were analysed as % changes from pre-
treatment concentrations.
Results
Plasma concentrations of E2
All animals had similar and non-detectable concentrations of E2 pre-
treatment.  Peak concentrations of E2 following all treatments (Table 1)
were significantly higher than pre-treatment concentrations and higher
than those in untreated control animals.  The interval (hours) from
administration of ODB to peak E2 concentration (Table 1) was similar
(P>0.1) in heifers given intramuscular injections (mean 13.4±1.24
hours), and was longer (P<0.05) in heifers given the 5 mg and 10 mg
ODB by intravaginal capsules (mean 25.5±2.84 hours).  Peak plasma
concentration of E2 increased with dose of ODB injected, (plasma E2 =
-0.237+16.109(dose)-0.74(dose)2, R2=0.75; P<0.05) but not when
given topically by the intravaginal route using the capsule. Peak
concentrations of E2 following use of the 5 and 10mg intravaginal
capsules were similar to each other and to those following the 0.5 mg
injection (P>0.05), but were lower than the concentrations in heifers
given 1 mg, 2.5 mg, 5 mg and 10 mg ODB intramuscularly (P<0.05).
The increase in plasma concentrations of E2 in animals following the 5
mg and 10 mg injections was prolonged and slower to return to pre-
treatment concentrations than in animals following all other treatments
(Table 1).  
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Plasma concentration of FSH
The effects of ODB administration on plasma concentrations of FSH
are presented in Table 2.  There was a significant decline in FSH
concentration following all ODB treatments (P<0.05) and the
magnitude of this decline was greater as the blood concentration of E2
increased. The maximum decline in FSH concentration expressed as
percentage of the pre-treatment concentrations, was significantly greater
following the 5 mg and 10 mg injections than following all other ODB
treatments.  Across all treatments, both the maximum percentage decline
in FSH and the interval to reach that decline were related to the peak
plasma concentrations of E2 (maximum % decline in FSH =
11.17+1.564(peak E2)-0.009(peak E2)
2, R2=0.75; P<0.005), (hours to
FSH nadir = 10.628+1.486(hours to peak E2)-0.0282(hours to peak
E2)
2, R2=0.22; P<0.05).  Following nadir concentrations, FSH increased
as the E2 concentration declined from peak value, irrespective of
treatment.  However, at the higher injected doses, concentrations of
FSH begin to rise again in the face of declining but still elevated plasma
concentrations of E2.  Concentrations of FSH following the 5 mg and
10 mg injections took significantly longer to return to pre-treatment
concentrations than in animals assigned to all other treatments (P<0.05).
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Figure 1. Effect of different doses of oestradiol benzoate (ODB)
administered either by gelatine capsule (10 mg dose) attached to
progesterone releasing device or two doses (1.0 and 10.0 mg) dissolved
in 2 ml of corn oil and administered by intramuscular injection to
ovariectomised heifers at the time of progesterone releasing device
insertion on mean plasma concentrations of oestradiol (E2 – dotted
lines) and FSH (solid lines) in ovariectomised heifers (n=4 heifers per
dose).
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Table 1.    E
ffect of O
D
B
 adm
inistration using different doses and routes of adm
inistration on characteristics of plasm
a
concentrations of oestradiol (M
ean ±
S.E
.) in ovariectom
ised heifers given a progesterone intravaginal device.
O
D
B
N
o. O
f
P
re-treatm
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Peak
N
o. of hours to
N
o. of hours
N
o. of hours
Treatm
ent
heifers
C
oncentrations
C
oncentration
h m
axim
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to reach < 3
to reach < 1
(m
g) 
(n) 
of E
2
O
f E
2
(pg/m
l) 
concentration of E
2
pg/m
l of E
2
pg/m
l of E
2
C
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0.0
3 
0.1 
0.1±0.05 a
Topical adm
inistration by 
intravaginal capsule
5.0
4
0.1
3.8±7.1 b
25.5±4.2 ad
54.0±23.8 a
72.0±19.4 a
10.0
5 
0.1 
4.1±6.3 b
27.6±3.7 bd
43.5±16.8 a
87.6±17.3 a
Intram
uscular injection 
in 2m
l corn-oil 
0.5
4
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1.0
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2.5
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0.1
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5.0
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158.0±19.4 b
188.0±22.4 d
W
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n, treatm
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ith different superscripts are significantly different (P<0.05).
13
Ta
bl
e 
2.
E
ff
ec
t 
of
 O
D
B
 a
dm
in
is
tr
at
io
n 
us
in
g 
di
ff
er
en
t 
do
se
s 
an
d 
ro
ut
es
 o
f 
ad
m
in
is
tr
at
io
n 
on
 c
ha
ra
ct
er
is
ti
cs
 o
f 
FS
H
 c
on
ce
nt
ra
ti
on
s 
  (
M
ea
n
±
S.
E
.)
 i
n 
ov
ar
ie
ct
om
is
ed
 h
ei
fe
rs
 g
iv
en
 a
 p
ro
ge
st
er
on
e 
in
tr
av
ag
in
al
 d
ev
ic
e.
O
D
B
N
o.
 O
f
P
re
-t
re
at
m
en
t
M
ea
n
N
o.
 o
f 
ho
ur
s
M
ax
im
um
 
N
o.
 o
f 
ho
ur
s
N
o.
 o
f 
ho
ur
s
Tr
ea
tm
en
t
he
if
er
s
C
on
ce
nt
ra
ti
on
s
C
on
ce
nt
ra
ti
on
to
 r
ea
ch
 F
SH
de
cl
in
e
to
 r
ea
ch
 f
ir
st
fo
r 
FS
H
 t
o
(m
g)
 
(n
) 
of
 F
SH
 (
ng
/m
l)
 
of
 F
SH
 a
t
na
di
r 
in
 F
SH
 e
xp
re
ss
ed
FS
H
 r
is
e
re
tu
rn
 t
o 
pr
e-
na
di
r 
(n
g/
m
l)
as
 %
 o
f 
pr
e-
fo
llo
w
in
g 
na
di
r
tr
ea
tm
en
t
tr
ea
tm
en
t 
va
lu
es
 
co
nc
en
tr
at
io
ns
C
on
tr
ol
s 
 
0.
0
3 
95
.9
±1
6.
96
ab
(1
02
.9
±1
3.
1)
a
0.
0a
To
pi
ca
l 
ad
m
in
is
tr
at
io
n 
 
by
 i
nt
ra
va
gi
na
l 
ca
ps
ul
e
5.
0
4
11
0.
4±
13
.4
5a
b
81
.5
±1
1.
3b
24
.0
±4
.2
ad
26
.6
±6
.9
b
30
.0
±1
4.
9a
46
.5
±1
6.
92
a
10
.0
5 
97
.5
±1
2.
70
ab
78
.6
±1
0.
1b
24
.0
±3
.8
a
18
.9
±6
.2
b
33
.6
±1
3.
3a
57
.6
±1
5.
13
a
In
tr
am
us
cu
la
r 
in
je
ct
io
n 
in
 2
m
l c
or
n-
oi
l 
0.
5
4
10
0.
8±
9.
55
ab
78
.1
±1
1.
3b
19
.5
±4
.2
a
24
.3
±6
.9
b
25
.5
±1
4.
9a
38
.0
±1
9.
54
a
1.
0
4
12
9.
4±
3.
47
a
82
.5
±1
1.
3b
24
.0
±4
.3
a
36
.6
±6
.9
b
31
.5
±1
4.
9a
c
64
.5
±1
6.
92
a
2.
5
6
11
6.
5±
8.
37
ab
71
.2
±9
.2
b
24
.0
±3
.5
ac
40
.0
±5
.7
b
34
.0
±1
2.
2a
d
57
.0
±1
3.
82
a
5.
0
4 
10
8.
4±
18
.5
ab
31
.3
±1
1.
3c
37
.5
±4
.2
b
69
.7
±6
.9
c
45
.0
±1
4.
9b
18
3.
0±
16
.9
2b
10
.0
4
75
.2
±1
4.
11
b
22
.3
±1
3.
1c
34
.0
±4
.9
bc
d
69
.5
±8
.1
c
10
4.
0±
17
.2
bc
d
16
8.
0±
19
.5
4b
W
it
hi
n 
co
lu
m
n,
 t
re
at
m
en
ts
 w
it
h 
di
ff
er
en
t 
su
pe
rs
cr
ip
ts
 a
re
 s
ig
ni
fic
an
tly
 d
iff
er
en
t 
(P
<0
.0
5)
.
14
Discussion
This experiment clearly shows that the route of administration and dose
of ODB affect subsequent concentrations of E2 and FSH in blood.  The
concentration of E2 in blood was elevated faster following ODB
administered i.m. compared with topical application using gelatine
capsule attached to the progesterone-releasing device. Plasma
concentrations of oestradiol in heifers given ODB topically took over ten
hours longer to reach maximum concentration than in heifers given a
similar dose by i.m.  Peak concentrations of oestradiol in heifers were
twenty times greater for the 5 and 10-mg injections than similar doses
administered in powder form using the intravaginal capsule.  While peak
plasma concentration of E2 was not reached for a further ten hours in
these heifers, some of the oestradiol may have been lost before being
absorbed, given that the gelatine capsule dissolves within 6 hours. This
experiment demonstrates more efficient absorption following
intramuscular injection in oil than following intravaginal capsule
administration of ODB. The rate of absorption of ODB from an oil
solvent is slower than from an aqueous solvent, but the rate of
absorption is still faster than topical administration. Retrograde loss in
vaginal secretions may  also be a significant source of loss from the
vagina.
Peak E2 increased in a dose-dependent manner with dose injected but
not following capsule administration. Once peak plasma concentrations
were reached, the rate of decline of E2 was similar for all treatments.
This is the first experiment to show the difference between peak plasma
concentrations of E2 following administration of ODB by intramuscular
injection and intravaginal gelatine capsule. Some synchronisation
regimes have included the administration of 10-mg ODB in oil by
intramuscular injection, which would elevate concentrations of E2 to
pharmacological levels and result in slow return of E2 to basal cyclical
values.  While there is a dose-dependent elevation of E2 following
intramuscular injection, the same is not true following administration by
intravaginal capsule. Peak plasma concentrations were similar following
both 5 and 10-mg intravaginal doses (Table 1), demonstrating the
inefficiency of absorption of ODB by topical administration to vaginal
epithelium following dissolution of the gelatine capsule.
Increasing concentrations of E2 transiently suppress FSH concentration
in ovariectomised heifers that were given progesterone. The magnitude
of the decline in FSH was affected by the peak concentrations of E2
achieved. The duration of the transient suppression was dose-dependent
and with E2 blood concentrations of 80 pg/ml in animals following
10mg ODB intramuscularly in oil, the FSH suppression lasted
considerably longer, viz. up to 150 hours. This is the first report showing
an increase in FSH concentrations while plasma concentrations of E2
were still very high demonstrating that E2 is only one part of the negative
feedback mechanism involved in the control of FSH.  
15
Study 2.
The effect of oestradiol administered during the first follicle
wave in association with progesterone administration on
follicle wave dynamics and oestrous response in heifers
Background
Oestradiol  given at the start of a  progesterone treatment in cattle affects
follicle dynamics, however, the effectiveness of  different doses on
terminating the existing follicle wave, on the interval to new wave
emergence, on follicle wave status at progesterone withdrawal and on the
lifespan of the corpus luteum are not known. Furthermore, there is
evidence that it is more difficult to induce a highly synchronised heat
and ovulation in animals that are the early stages of their oestrous cycles
at time of treatment initiation. The objective of this study was to
determine if the follicle and oestrous response to exogenous oestradiol
was dose- and follicle status-dependent.
Materials and Methods
Ninety-one crossbred beef heifers, 18-24 months of age, weighing 310-
480 kg were used.  Heifers were synchronised with prostaglandin.
Heifers (n=81) were given a progesterone releasing intravaginal device
during distinct stages of development of the first follicle wave following
the synchronous heat.  At progesterone insertion, heifers were randomly
assigned to receive one of four plasma concentrations of oestradiol (E2)
as follows: 1) 0, 2) low 2-4 pg/ml by use of 10mg ODB by gelatine
capsule, 3) medium 15-20 pg/ml by 0.75mg ODB i.m. injection in 2ml
corn oil or 4) high 40-60 pg/ml by 5mg ODB i.m. in oil. These plasma
concentrations of oestradiol and doses of ODB were derived from the
results of Study 1.   The treatments were administered at i) emergence
(E), ii) 1st day of dominance (DOM1) and iii) 4th day of dominance
(DOM4) of the 1st follicle wave (see Figure 2).  The design was,
therefore, a 4x3 factorial with four dose of ODB administered at three
distinct follicle stages.  The progesterone releasing devices were left in
place for 12 days.  Ten heifers remained untreated (controls).  Heifers
remained on the experiment until heat and ovulation had occurred
following treatment. Heifers were observed for heat four times daily
from 36 hours following progesterone removal. 
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Ovarian Ultrasonography 
Ovarian follicle dynamics of all heifers were monitored once daily from
the day following the second PG injection until ovulation following
treatment. The emergence of a follicle wave was defined as the
development of a cohort of small follicles that measured between 4 - 5
mm in diameter.  Dominance was determined as the 1st day a follicle
became dominant.  A dominant follicle was defined as the largest follicle
present on either ovary, that was at least 8.5 mm in diameter and at least
2 mm larger than all other follicles on either ovary, and suppressed the
growth of other follicles.  Duration of dominance of a dominant follicle
was defined as the interval in days from the 1st day on dominance to the
emergence of the subsequent wave.  Ovulation was taken as the day in
which a dominant follicle was no longer detectable, followed by the
development of a corpus luteum in the position previously occupied by
the ovulatory follicle.
Blood sampling and hormone assays
Blood samples were collected for progesterone, FSH and oestradiol
determination. Plasma concentrations of  progesterone, FSH and
oestradiol were determined by radioimmunoassays. 
Statistical analyses
Follicle data were analysed using analyses of variance (SAS, 1998).
Hormone data were analysed using repeated measures analyses of
variance followed by regression analyses (SAS, 1988). Because of the
between animal variability, concentrations of FSH were analysed as %
changes from pre-treatment concentrations.
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Results 
Effect of different dose of ODB on plasma concentrations of oestradiol
Different ODB treatments generated significantly different (P<0.05)
and distinct peak plasma concentration of E2, irrespective of the stage of
the follicle wave at which treatment was initiated (see Figure 3). Peak
concentrations of E2 were higher (P<0.01) at all stages of the follicle
wave following the administration of 5-mg ODB by injection, than all
other doses used. A dose 0.75 mg of ODB generated peak plasma
concentrations of 8-15 pg/ml which, were higher than concentrations of
3-5 pg/ml generated by the 10mg capsule of ODB attached to the
progesterone releasing device. 
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Figure 2. Schematic representation of treatments relative to stage of follicle
wave follicle wave.
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Effect of dose ODB on fate of first follicle wave
The administration of progesterone, irrespective of accompanying dose
of ODB, at emergence of the first follicle wave altered the course of the
first follicle wave with fewer (P<0.05) ODB-treated (11/26; 42%)
forming a 1st DF compared with control heifers (10/10;100%). More
animals that received ODB by injection  (10/13; 77%) formed a new
follicle wave compared with animals receiving progesterone only or
progesterone  + ODB by capsule (3/11;27%; P<0.05)
Effect of exogenous progesterone and different doses of ODB on plasma
concentrations of progesterone
Plasma concentrations of progesterone increased rapidly following
progesterone administration with highest concentrations recorded in
animals treated on the 1st (DOM1) and 4th day (DOM4) of
dominance (Figure 4).  At 24 hours after progesterone withdrawal (Day
13, Figure 4) plasma concentrations of progesterone were lowest
(P<0.05) in animals receiving ODB irrespective of dose compared with
control or animals not receiving ODB. The lower concentrations of
progesterone on Day 13 was reflected in the shorter interval to onset of
heat following withdrawal of the exogenous progesterone (Table 4) 
Effect of exogenous progesterone and different doses of ODB on plasma
concentrations of FSH 
Irrespective of the stage of the follicle wave at treatment initiation the
administration of progesterone only or progesterone + ODB caused a
transitory decrease in plasma FSH (Figure 5 and Table 3.). The greatest
% decline in FSH was caused by the administration of 5.0-mg ODB by
injection.
Heat response and synchrony of heat
The overall heat response was high and similar for all treatments. The
synchrony of heat, measured as the proportion of animals observed in
heat on days 2 and 3 following progesterone removal was similar
(P>0.05) for heifers receiving progesterone only (45%) or progesterone
+ ODB by capsule (55%). Similarly, the synchrony of heat was similar
(P >0.05) for animals which received 0.75 mg (78%) or the 5.0 mg
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(60%) ODB by injection. The overall synchrony of heat was higher
(P<0.05) for animals receiving ODB by injection (27/39;69%)
compared with animals receiving no ODB or ODB by gelatine capsule
(50%). 
External appearance of bovine ovary showing corpus luteum (CL) and large
dominant follicle. For good synchrony of heat and good fertility it is
necessary to control the life span of the CL and to ensure that there is a
“healthy” oestrogen active follicle present at the time of progesterone
withdrawal.
Corpus luteum
(CL)
Dominant follicle
(DF)
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Figure 3. Plasma concentrations of oestradiol generated by different
doses and routes of oestradiol administration in conjuncton with
exogenous progesterone at three distinct stages of the  first follicle
wave.
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Figure 4. Plasma concentration of progesterone in heifers receiving
exogenous progesterone and different doses of oestradiol benzoate at
three distinct stages of the first follicle wave of the oestrous cycle 
23
Figure 5. Relative changes in plasma concentrations of FSH following
the administration of exogenous progesterone and different doses of
ODB at different stages of the first follicle wave of the oestrous cycle
Emergence
Dominance (DOM1)
At 4th Day of Dominance (DOM4)
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Table 3.  T
he effect of dose and route of oestradiol benzoate (O
D
B
) on plasm
a concentrations of FSH
 (ng/m
l) w
hen adm
inistered
at different stages of developm
ent of the first dom
inant follicle in beef heifers (M
ean ±
S.E
.) 
Param
eter 
Follicle stage  
Treatm
ent
C
ontrol 
P
rogesterone
P
rogesterone
P
rogesterone 
P
rogesterone
alone 
+ 10 m
g  cap. 
+ 0.75 m
g  i.m
.
+ 5.0 m
g i.m
. 
P
re-treatm
ent concentrations of      E
m
ergence
11.7±2.5
6.6±2.5 a
14.5±2.2 b
12.5±2.2
11.8±2.2
FSH
 (ng/m
l) (3 values)
D
O
M
1
7.2±2.5
4.5±2.2
7.0±2.5
6.2±2.5
8.7±2.5
D
O
M
4
17.4±2.5
9.6±2.5 b
18.6±2.2 a
11.5±2.2 b
9.0±2.0 b
%
 decline in FSH
 (ng) from
E
m
ergence
70±12.7 a
16±12.7 b
48±11.0 a
44±11.0 a
84±11.0 a
pre-treatm
ent values
D
O
M
1               0.0±1.8 a         29±11.0 ab            41±12.7 bc         56±12.7 bc        66±12.7 c
D
O
M
4
46±12.7 ab
23±12.7 a
53±11.0 bc
58±11.0 bc
80±9.8 c
D
uration of decline in FSH
 
E
m
ergence
0.5±0.3
0.9±0.3
0.6±0.3
0.9±0.3
(days)
D
O
M
1
0.3±0.8
0.7±0.3
0.6±0.3
0.6±0.3
D
O
M
4              
0.2±0.3 a
0.6±0.3
0.8±0.3
1.1±0.2 b
M
ean m
axim
um
 conc. (ng/m
l)
E
m
ergence
20.9±3.8
20.9±4.4
16.8±3.8
27.2±3.8
23.2±3.8
of FSH
 achieved follow
ing nadir
D
O
M
1
20.7±4.4
17.2±3.8
26.7±4.4
20.0±4.4
24.0±4.4
(ie.+ Peak of next w
ave)
D
O
M
 4
36.0±4.4 a
20.4±4.4
27.9±3.8 a
21.0±3.8 b
14.9±3.4 b
Interval from
 treatm
ent to peak
E
m
ergence
5.2±1.0
4.0±1.2
4.6±1.0
2.9±1.0
4.5±1.0
of w
ave 2 (days) independent of 
D
O
M
1
3.2±1.2
4.0±1.0
3.0±1.2
5.7±1.2
5.8±1.2
N
.W
.E
. 
D
O
M
4
9.7±1.2 a
4.0±1.2 b
6.2±1.0 b
4.8±1.0 b
5.9±0.9 b
Interval from
 treatm
ent to peak 
E
m
ergence
6.8±1.1 a
4.0±1.1 ab
4.9±0.9 ab
3.6±0.9
6.4±0.9 a
of next w
ave (days) associated
D
O
M
1
3.3±1.1
4.0±0.9
3.0±1.1 a
5.7±1.1
6.0±1.1 b
w
ith N
.W
.E
.
D
O
M
4
0.4±1.1 a
1.8±1.1 a
4.6±0.9 b
5.1±0.9 b
5.9±0.8 b
Inter - peak – interval (days)
E
m
ergence
7.3±1.2
6.0±1.2
5.8±1.1
4.2±1.1
5.5±1.1
D
O
M
1
7.3±1.2
8.1±1.2
7.2±1.2
9.5±1.2
9.5±1.4
D
O
M
4 
7.3±1.2 a
10.6±1.2 ab
12.5±1.1 bc
11.5±1.5 bc
14.2±0.9 c
W
ithin row
, treatm
ents w
ith different superscripts are significantly different (P < 0.05).
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Discussion
The results of this experiment clearly showed that the administration of
exogenous oestradiol, in the form of oestradiol benzoate (ODB), causes
a dose-dependent increased in plasma concentrations of oestradiol and a
dose-dependent decrease in plasma FSH, and, in a high proportion of
animals causes atresia of the follicle wave present at treatment initiation
followed by the emergence of new follicle wave 3 to 6 days later. The
results of this study are consistent with those of Study 1, where an
ovariectomised heifer model was used to establish the circulating
concentrations of oestradiol generated by different doses of exogenous
ODB. This study also clearly demonstrated that the administration of
oestradiol, by a capsule attached to the progesterone releasing device, was
the least effective way of administering oestradiol in terms of its ability
to generate plasma concentrations of 5-15 pg/ml which, would appear
to be required in order to terminate the current follicle wave and cause
new wave emergence 3-6 days later. It was also clear from the both
plasma progesterone profiles, which represent endogenous and
exogenous sources of progesterone, and from the shorter intervals from
progesterone withdrawal to heat onset, that exogenous oestradiol
significantly shortened the lifespan of the current corpus luteum. It
would appear that while the low plasma concentrations of 3-5 pg/ml
generated by the gelatine capsule attached to the progesterone releasing
device were insufficient to consistently alter follicle wave dynamics and
ensure new emergence they was sufficient to shorten the lifespan of the
corpus luteum. This is the first study to demonstrate that a lower dose
of oestradiol is required to shorten the lifespan of the CL than is required
to alter follicle wave dynamics. 
The results of this study clearly demonstrated the difficulty of obtaining
a tight synchrony of heat in animals that are at early stages of their
oestrous cycles at time of treatment initiation. Tight synchrony of
oestrus will only occur when the CL is regressed and when a recently
dominant, oestrogen-active follicle is present at time of progesterone
withdrawal. The use of oestradiol at the beginning of a progesterone
synchronisation treatment, even when the duration of the treatment is
extended to 12 days, does not ensure that corpus luteum regression is
complete in all animals at the time of, or, 24 hours after progesterone
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withdrawal, thus allowing animals to exhibit a synchronous heat.
Consequently, there is a requirement to administer a luteolytic agent like
prostaglandin F2α or one of its analogues at or before progesterone
withdrawal to ensure complete corpus luteum regression.
While there was clear evidence that administration of oestradiol by
injection was superior to administration by a capsule attached the
progesterone  releasing device there was no evidence of any beneficial
effects of increasing the dose of oestradiol from 0.75-mg /animal to 5-
mg/animal in terms of controlling follicle wave dynamics, shortening the
lifespan of the corpus luteum, or in terms of synchrony of heat or overall
heat response. In fact there was a suggestion in the data that the
synchrony of the heat response, measured in terms of the proportion of
treated animals observed in heat on days 2 and 3 after progesterone
withdrawal, was lower in animal receiving the 5 mg of ODB by
injection. Numerically the tightest synchrony of heat was obtained in
animals receiving the 0.75-mg of ODB by injection.
Study 3
Effect of duration of progesterone treatment, with or without
oestradiol benzoate, on synchronised oestrous response and
fertility in beef cows and heifers 
Background
The critical requirements for successful synchronisation of the oestrous
cycle in cattle are a consistent and high oestrous response during a
specified 12- to 24-hour period and a high pregnancy rate following
insemination. To date these requirements have not been generally met.
Earlier studies have shown that progestagen treatments of  more than 14
days duration resulted in good synchrony of oestrus but low pregnancy
rates. When the treatment period was reduced to 9-12 days by the
administration of oestradiol at the start of the progestagen treatment,
this resulted in a normal pregnancy rate but a greater variability in the
onset of oestrus. The use of prostaglandin (PG) at or near the end of the
progestagen period increased the oestrous response in animals with a
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corpus luteum, but failed to give a sufficiently precise onset of heat to
allow high pregnancy rates to a single fixed-timed A.I. An alternative
approach to improve the synchrony of oestrus is to induce the
synchronous occurrence of the proestrous oestradiol rise by the
exogenous administration of oestradiol after withdrawal of the
progesterone. The aims of this experiment were to determine the effects
of 1) the duration of progesterone treatment and 2) of administering 1.0
mg oestradiol benzoate (ODB) 24 hours after progesterone   removal on
oestrous response and on pregnancy rates in beef cows and heifers.
Material and Methods
A total of 297 beef cows and 163 beef heifers, in 15 herds, were used in
a farm trial. The progesterone  synchronisation  treatments were either
of 12- or 8-day duration. Prior to insertion, the oestradiol benzoate
capsule, normally attached to the progesterone releasing device, was
removed. All animals received 0.75 mg ODB by intra-muscular
injection at the start of the synchronisation. All animals receiving
progesterone for 8 days received PG 24 hours prior to the end of the
progesterone treatment. Twenty four hours after removal of the
progesterone half of the animals received 1.0 mg of ODB.
Approximately 20% of each herd were left untreated and were
inseminated at an observed heat. The treatments were: 
1. 12-day progesterone 
2. 12-day progesterone + 1.0 mg ODB 24 hours after
progesterone removal.
3. 8-day progesterone  + PG on Day 7
4. 8-day progesterone + PG on Day 7 + 1.0 mg ODB 24 hours
after  progesterone removal.
5. Untreated controls
At progesterone removal all animals were tail-painted and observed for
heat 4 times daily for 4 days and inseminated once at 6-12 hours after
the first observation of  heat.  On each farm and within each animal
category (cows or heifers) semen from one bull was used. One
inseminator was used in each herd.  All animals were scanned for
pregnancy at 30-40 days after insemination. 
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Data analysis
Heat response and pregnancy rate data was analysed using PROC
CATMOD (SAS, 1988).
Results
The was no interaction (P>0.05) between the duration of the
synchronisation treatment (8-day and 12-day) and ODB treatment 24
hours after progesterone  removal on heat response or pregnancy rate.
However, the effect of treatments on heat response and pregnancy rates
was different in cows and heifers (treatment x parity interaction P<0.05).
The overall heat response was similar for 12-day (151/173; 87%) and 8-
day (157/173; 91%) synchronisation treatments. There was a tendency
for better synchrony in heifers than cows and the 8-day progesterone +
ODB given 24 hours later tended to give the best synchrony. Heat
response was higher in cows following the administration of ODB
(P<0.05) (Table 5).  In heifers, heat response was high following all
treatments and was unaffected (P>0.05) by ODB treatment after
progesterone removal.  
Table 5. The effect of duration of progesterone treatment with or without the
administration of ODB 24hrs after progesterone removal on overall
oestrous response (%) in beef cows and heifers.
Within row, treatments with different superscripts are significantly different (P<0.05)
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Animal Treatment + 1.0mg ODB 0mg ODB Controls
Category 
12-day 
Beef Progesterone 48/51 (94)a 42/55 (76)b
cows 8-day 71/81 (88)  
Progesterone 50/54 (93)a 44/56 (78)b
12-day
Beef progesterone 32/35 (91) 29/32 (91)
Heifers 8-day 30/33 (91)
progesterone  32/32 (100) 31/31 (100)
Synchrony of oestrous response
The pattern of heat onset following different synchronisation treatments
in both beef cows and heifers is presented in Fig  6. Duration of
treatment had no effect on the % of cows observed in heat (12-Day:
75%; 8-Day: 75%) on Day 2 after  progesterone removal. In heifers
there was a tendency for more heifers to be in heat on Day 2 following
progesterone removal following an 8-Day (86%) than a 12-Day (76%)
treatment. The administration of 1.0 mg of ODB 24 hours after
progesterone withdrawal improved the synchrony of oestrous response in
both cows and heifers with a higher (P<0.05) proportion of ODB-
treated animals (88%) than non-ODB treated animals (76%) observed
in oestrus on Day 2 following progesterone  removal. 
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Fig 6.  The effect of duration of progesterone treatment with or without
the administration of 1.0 mg of ODB 24 hours after progesterone
removal on oestrous response and pattern of onset of oestrus in beef
cows (upper panel) and beef heifers (lower panel). Oestrous
response is expressed as  % of animals initially treated.
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Pregnancy rate.
Pregnancy rates defined as the % of cows conceiving following
insemination at a synchronisation induced-oestrus as a % of animals
initially inseminated are presented in Table 6. In heifers, duration of
progesterone treatment (8-day versus 12-day) had no effect (P>0.05) on
pregnancy rate. The use of ODB 24 hours after progesterone removal
reduced (P<0.05) pregnancy rates in heifers but had no effect on
pregnancy rate in cows.   In beef cows overall pregnancy rate, irrespective
of ODB treatment and duration of  progesterone treatment,  was lower
(P<0.05) for treated cows (59%) than for untreated (75%) control cows
while in heifers pregnancy rate was similar (P>0.05) in treated (63%)
and control animals (67%).
Table 6.  The effect of duration of progesterone treatment with or without the
administration of ODB 24hrs after progesterone removal on pregnancy
rate  (%) in beef cows and heifers. 
Within row, treatments with different superscripts are significantly different (P<0.05)
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Animal Treatment + 1.0mg 0mg ODB Controls
Category ODB 
12-day 
Beef Progesterone 26/48 (54) 24/42 (57)
cows 8-day 53/71(75)   
Progesterone 31/50 (62) 28/44 (64)
12-day
Beef progesterone 12/32 (38)a 20/29 (69)b
Heifers 8-day 20/30 (67)
progesterone  13/32 (41)a 18/31(58)b
Conception  Rate
Conception rates defined as the % of cows conceiving following
insemination at a synchronisation induced-oestrus as a % of animals
initially treated are presented in Table 7.
Table 7.  The effect of duration of progesterone treatment with or without the
administration of ODB 24hrs after progesterone removal on conception
rate (%) in beef cows and heifers. 
Within row, treatments with different superscripts are significantly different (P<0.05)
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Animal Treatment + 1.0mg 0mg ODB Controls
Category ODB 
12-day 
Beef Progesterone 26/51 (51) 24/55 (44)
cows 8-day 53/71(75)
Progesterone 31/54 (57) 28/56 (50)
12-day
Beef progesterone 12/35(34)a 20/32 (63)b
Heifers 8-day 20/30 (67)
progesterone  13/32 (41)a 18/31(58)b
Figure 7.  Effect of ODB administration 24 hours after progesterone
withdrawal on conception rate in beef cows.
In cows conception rate tended to be higher following an 8-Day (54%)
than a 12-Day  (47%) duration treatment irrespective of ODB
treatment. For beef cows the overall benefit of using 1.0 mg ODB 24
hours after progesterone removal is presented in Figure 7.  
Discussion
In these farm trial studies there was no effect of progesterone duration
(8-day versus 12-day) on oestrous response in either beef cows or heifers
though there was some evidence that the oestrous response tended to be
higher following an 8-day treatment. Similarly, duration of treatment
had no effect on the synchrony of the oestrous response following
withdrawal of the progesterone though there was some evidence of a
more highly synchronised oestrous response following the 8-day
treatment. The use of 1.0 mg oestradiol 24 hours after progesterone
removal significantly increased synchronised oestrous response in beef
cows, with almost all cows exhibiting oestrus on Day 2 following
withdrawal of the progesterone. However, in heifers oestrous response at
91% in the non- ODB treated heifers was already high and would have
been difficult to improve on. This highly synchronised oestrous response
following the administration of ODB would allow one fixed-timed AI at
about 54-56 hours after withdrawal of progesterone in beef cows. 
In cows there was a tendency for the pregnancy rate to be higher
following an 8- than a 12-day progesterone treatment. The lower
pregnancy rate following the longer duration treatment may be the result
of the ovulation of follicles with an excessive long period of dominance
caused by the 12-day treatment. The administration of ODB had no
effect on pregnancy rate in beef cows but significantly reduced
pregnancy rate in heifers. It would appear that the dosage used in heifers
was excessive and that a lower dose would be more appropriate.
However, the high and synchronous oestrous response recorded in
heifers would obviate the need to use ODB after progesterone removal
in heifers. 
In beef cows the overall benefit of using ODB is evident by the higher
conception rate (+7 percentage points), defined as the proportion of
animals initially treated that conceived at the synchronised oestrus. This
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results from a small increase in both the oestrous response and pregnancy
rate in ODB-treated animals.
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An 8-day progesterone treatment, with 0.75 mg of ODB at start,
prostaglandin (PG) administered 24 hours before and 1.0 mg ODB
administered 24 hours after progesterone removal will give a highly
synchronous heat response in beef cows facilitating fixed-times AI at 54-56
hours after progesterone removal. Average conception rates of 55-60%  are
achievable. 
CONCLUSIONS
• The administration of exogenous oestradiol by injection, in the form
of oestradiol benzoate (ODB), resulted in dose-dependent increase
in peak plasma oestradiol and a dose-dependent transient decrease in
follicle stimulating hormone (FSH) in ovariectomised heifers. 
•    Administration of higher doses (5mg and 10mg) of oestradiol by
capsule attached to a progesterone releasing intravaginal devise
generated much lower plasma concentrations of oestradiol compared
with the lowest dose (0.75mg) of oestradiol administered
intramuscularly. Both the maximum % decline in FSH and interval
to FSH nadir were related to peak concentrations of oestradiol. 
•    Plasma concentrations of FSH began to increase 1-2 days after ODB
administration while concentration of oestradiol were declining but
still high.
• The administration of ODB, caused a dose-dependent increased in
plasma concentrations of oestradiol and a dose-dependent decrease
in plasma FSH in intact heifers, and, in a high proportion of animals
caused atresia of the follicle wave present at treatment initiation
followed by the emergence of new follicle wave 3 to 6 days later. 
• The administration of oestradiol, by a capsule attached to the
progesterone releasing device, was the least effective way of
administering oestradiol in terms of its ability to generate plasma
concentrations of 5-15 pg/ml which, would appear to be required to
terminate the current follicle wave and cause new wave emergence.
The low plasma concentrations of 3-5 pg/ml generated by the
gelatine capsule attached to the progesterone releasing device were
insufficient to consistently ensure new follicle wave emergence but
were sufficient to shorten the lifespan of the corpus luteum. 
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•    The use of oestradiol at the beginning of a progesterone
synchronisation treatment with animals at the beginning of their
oestrous cycles, even when the duration of the treatment is extended
to 12 days, did not ensure that corpus luteum regression was
complete in all animals at the time of progesterone withdrawal, thus
allowing animals to exhibit a synchronous heat. Consequently, there
is a requirement to administer a luteolytic agent like prostaglandin
F2a at or before progesterone withdrawal to ensure complete corpus
luteum regression.
•  The administration of oestradiol by injection was superior to
administration by a capsule attached the progesterone releasing
device. There was no evidence of any beneficial effects of increasing
the dose of oestradiol from 0.75/animal to 5mg/animal in terms of
controlling follicle wave dynamics, shortening the lifespan of the
corpus luteum, or in terms of synchrony of heat or overall heat
response. 
•   There was no effect of progesterone duration (8-day versus 12-day)
on oestrous response in either beef cows or heifers though in the latter
oestrous response tended to be higher following an 8-day treatment.
Similarly, duration of treatment had no effect on the synchrony of the
oestrous response following withdrawal of the progesterone though
there was some evidence of a more highly synchronised oestrous
response following the 8-day treatment. 
•   The use of 1.0-mg oestradiol, 24 hours after progesterone removal,
significantly increased synchronised oestrous response in beef cows.
However, in beef heifers it had no beneficial effect, though in this
group oestrous response at 91% in the non- ODB treated heifers was
already high and would have been difficult to improve on. 
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•   The use of ODB improved the synchrony of oestrous response with
almost all cows exhibiting oestrus on Day 2 following withdrawal of
the progesterone. This highly synchronised oestrous response
following the administration of ODB would allow one fixed-timed
AI at about 54-56 hours after withdrawal of the progesterone. In
cows there was a tendency for the pregnancy rate to be higher
following an 8-day than a 12-day duration progesterone treatment.
•   The administration of ODB had no effect on pregnancy rate in beef
cows but significantly reduced pregnancy rate in heifers. It would
appear that the dosage used in heifers was excessive and that a lower
dose would be more. However, the high and synchronous oestrous
recorded in heifers would obviate the need to use ODB after
progesterone removal in heifers. 
•   The overall benefit of using ODB is evident by the higher conception
rate (+7 percentage points at the synchronised oestrus. This results
from a small increase in both the oestrous response and pregnancy
rate in ODB-treated cows.
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